Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>


Close X


Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more

Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.



As the landscape of patent procurement and enforcement continues to evolve, the patent team assists clients with a broad spectrum of issues, including the maintenance, litigation and prosecution of patents. Clients benefit from an integrated approach, which leverages the scientific backgrounds of patent prosecutors in areas such as pharmaceuticals, chemistry and biotechnology with an experienced team of litigators. We help clients uphold their rights by counseling on various aspects of enforcement and defense, and guiding them through complex litigation and post-grant proceedings when necessary. 

Patent Prosecution and Counseling

Our team has extensive experience in the strategic, cost-effective management of patent portfolios, including prosecution before the U.S. Patent and Trademark Office (USPTO), including the Patent Trial and Appeal Board (PTAB), and coordination of related international proceedings. We regularly assist clients with the preparation and prosecution of patent applications; counsel them on rendering opinions on patentability, reexamination procedures, and infringement; and evaluate patent portfolios.

Patent Litigation

Our litigators have extensive IP litigation experience in a wide range of scientific and technical fields, representing national and international clients in the federal district courts, U.S. Court of Appeals for the Federal Circuit, U. S. International Trade Commission and in proceedings before the USPTO. Our litigators have extensive experience in the federal courts where IP disputes are most often litigated, including the Eastern District of Texas, the Eastern District of Virginia, the District of Delaware, the Northern District of California, and the District of New Jersey, where we are consistently successful. The team is known for their skills in the courtroom and their ability to develop novel strategies to resolve matters in an efficient and cost-effective method. Our experience in handling both complex and routine cases, coupled with a deep understanding of our clients' businesses, puts us in a unique position to help clients achieve their strategic business objectives.

Proceedings Before the USPTO Patent Trial and Appeal Board (PTAB)

Our attorneys represent both petitioners and patent owners in the evolving landscape of post-grant proceedings introduced by the Leahy-Smith America Invents Act. The team's breadth of experience in patent litigation matters, combined with our patent prosecution experience before the USPTO, enables us to help clients successfully navigate the intricacies of the PTAB's procedural rules, including those related to inter partes review and post-grant review. These proceedings are often completed within one year, making them a faster and more cost-effective alternative to traditional litigation, but they also require a deep understanding of the technical intricacies of the patents in question. We routinely include the new procedures in conjunction with our overall defense strategy. For example, we use IPR proceedings in the USPTO to challenge the validity of the asserted patents and simultaneously achieve a stay of pending federal district court litigation. By utilizing a comprehensive approach to patent law, we provide a solution that is efficient and more cost-effective than conventional litigation.


View More

Related Experiences

View More

Related Professionals


Viewing 0 of 0 Results

View More


View More

Upcoming Events

Past Events

View More

Media Mentions

View More




Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.